logo

Sarepta Therapeutics (SRPT)



Trade SRPT now with
  Date
  Headline
11/17/2021 8:40:30 AM Sarepta Therapeutics Appoints Stephen Mayo To Board
11/3/2021 5:29:15 PM Sarepta Therapeutics Q3 Loss/share $0.60 Vs. Loss $2.50 Year Ago
10/4/2021 7:27:20 AM Sarepta Therapeutics Begins Pivotal Study Of SRP-9001 For The Treatment Of Duchenne Muscular Dystrophy
3/1/2021 4:35:22 PM Sarepta Therapeutics Q4 Loss/share $2.40 Vs. Loss $3.16 Year Ago
1/13/2021 8:45:41 AM Sarepta,Genevant Enter Research Collaboration For Lipid Nanoparticle-Based Gene Editing Therapeutics
11/5/2020 5:09:38 PM Sarepta Therapeutics Q3 Loss/Shr $2.50 Vs Loss $1.70 Prior Year
9/14/2020 8:41:35 AM Sarepta Therapeutics To Present New Data From Its Most Advanced Gene Therapy Programs